A fecal calprotectin assay designed for rapid detection and quantification of intestinal inflammation. Used in gastroenterology for diagnosis and monitoring of inflammatory bowel diseases.
Manufactured by
United States
BUHLMANN Diagnostic Corp (BDC) offers the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo (Elastase); Tests available as RUO include: Quantum Blue® fCAL rapid tests & Quantum Blue® Infliximab & Adalimumab TDM and Antibody rapid test.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Gentian USA Inc
United States · 10 relevant products
VEDALAB SAS
France · 4 relevant products
Hipro Biotechnology Co., Ltd. CE CIBG
China · 1 relevant product
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 89 closest product alternatives
Gentian USA Inc · United States
An immunoturbidimetric method for quantification of calprotectin in fecal samples. The method provides flexibility and when combined with automation and short analysis time becomes an ideal solution for clinical laboratories with varying sample volumes. It can be set up on all automated chemistry analyzers with a measurement range of 20-8000 µg/g calprotectin. When combined with the BÜHLMANN CALEX® Cap extraction device with pre-filled extraction tubes, sample extraction is simplified and performed more hygienically.
Gentian USA Inc · United States
A particle enhanced turbidimetric immunoassay (PETIA) test for quantitative determination of pancreatic elastase in human fecal extracts, designed to run on clinical chemistry analyzers. The test is developed to run directly with stool extracts from the CALEX® Cap extraction device. Fecal pancreatic elastase is a well-established biomarker to detect exocrine pancreatic insufficiency in patients with conditions such as chronic pancreatitis and cystic fibrosis.
VEDALAB SAS · France
CE-marked rapid test for detection of faecal calprotectin associated with intestinal inflammation. Supports non-invasive assessment of inflammatory bowel disease and gastrointestinal inflammation.
86 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products